Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1
Parasites, Hosts and Diseases · 2024
DOI: 10.3347/phd.24017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasites, Hosts and Diseases, 2024. Verfasst von Min-Ju Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Korea. Hauptthemen laut MEDLINE: Antigens, Protozoan, Malaria Vaccines, Membrane Proteins, Plasmodium berghei. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Core Research Institute, National Research Foundation of Korea, Ministry of Education.
Abstract (Originalsprache)
Malaria is a global disease affecting a large portion of the world’s population. Although vaccines have recently become available, their efficacies are suboptimal. We generated virus-like particles (VLPs) that expressed either apical membrane antigen 1 (AMA1) or microneme-associated antigen (MIC) of Plasmodium berghei and compared their efficacy in BALB/c mice. We found that immune sera acquired from AMA1 VLP- or MIC VLP-immunized mice specifically interacted with the antigen of choice and the whole P. berghei lysate antigen, indicating that the antibodies were highly parasite-specific. Both VLP vaccines significantly enhanced germinal center B cell frequencies in the inguinal lymph nodes of mice compared with the control, but only the mice that received MIC VLPs showed significantly enhanced CD4+ T cell responses in the blood following P. berghei challenge infection. AMA1 and MIC VLPs significantly suppressed TNF-α and interleukin-10 production but had a negligible effect on interferon-γ. Both VLPs prevented excessive parasitemia buildup in immunized mice, although parasite burden reduction induced by MIC VLPs was slightly more effective than that induced by AMA1. Both VLPs were equally effective at preventing body weight loss. Our findings demonstrated that the MIC VLP was an effective inducer of protection against murine experimental malaria and should be the focus of further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul 02447, Korea.
- Department of Parasitology, Inje University College of Medicine, Busan 47392, Korea.
- Department of Infectious Disease and Malaria, Paik Institute of Clinical Research, Inje University, Busan 47392, Korea.
- Department of Microbiology, Dongguk University College of Medicine, Gyeongju 38066, Korea.
- Department of Medical Zoology, Kyung Hee University School of Medicine, Seoul 02447, Korea.
- Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, School of Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea.
Förderung
- Core Research Institute
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Kim, M. J., Chu, K. B., Yoon, K. W., Kang, H. J., Lee, D. H., Moon, E. K., & Quan, F. S. (2024). Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1. Parasites, Hosts and Diseases. https://doi.org/10.3347/phd.24017
Vancouver
Kim MJ, Chu KB, Yoon KW, Kang HJ, Lee DH, Moon EK, et al. Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1. Parasites, Hosts and Diseases. 2024. doi:10.3347/phd.24017
BibTeX
@article{Kim2024,
author = {Kim, Min-Ju and Chu, Ki Back and Yoon, Keon-Woong and Kang, Hae-Ji and Lee, Dong-Hun and Moon, Eun-Kyung and Quan, Fu-Shi},
title = {Virus-like particles expressing microneme-associated antigen of Plasmodium berghei confer better protection than those expressing apical membrane antigen 1},
journal = {Parasites, Hosts and Diseases},
year = {2024},
doi = {10.3347/phd.24017}
}
EUVIMED